PATH-BREAKING SCIENCE AND PLATFORM

TO POWER TRANSFORMATIVE THERAPEUTICS

PRESS RELEASES

• June 23, 2021
  Omega Therapeutics Expands Board of Directors with Appointment of Luke Beshar
• May 20, 2021
  Omega Therapeutics Strengthens Board of Directors with Appointment of R&D Veteran Elliott M. Levy, M.D.
• March 30, 2021
  Omega Therapeutics to Advance Pipeline and Platform Development with $126 Million in Additional Financing
• January 13, 2021
  Omega Therapeutics Announces the Industry’s First Programmable Epigenetic Medicine in Development and 2021 Priorities
• January 6, 2021
  Omega Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference